Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Oncology in Practice
  3. Palliative and Supportive care
  4. Multikinase Inhibitor-Related Skin Toxicity
  5. Patients and Caregivers

Important to Know

Previous Page Next Page

  • Adverse reactions mentioned on this website usually respond well to treatment and generally disappear when cancer treatment is stopped. In some cases, treatment is not needed and the adverse reactions resolve spontaneously.
  • The earlier an adverse reaction is reported and treated, the better it can be managed.
  • By following the steps recommended on this website, you can help reduce the severity and duration of these adverse reactions.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.